BIGUANIDES
(metformin) |
SGLT2 INHIBITORS
(glifflozins) |
GLP1 RECEPTOR AGONISTS
(- tide's) |
DPP4 INHIBITORS
(gliptins) |
THIAZOLINEDIONES
(glitazones) |
Sulphonylureas
(- ide's) |
BIGUANIDES
(metformin) |
SGLT2 INHIBITORS
(glifflozins) |
GLP1 RECEPTOR AGONISTS
(- tide's) |
DPP4 INHIBITORS
(gliptins) |
THIAZOLINEDIONES
(glitazones) |
Sulphonylureas
(- ide's) |
BIGUANIDES
(metformin) |
SGLT2 INHIBITORS
(glifflozins) |
GLP1 RECEPTOR AGONISTS
(- tide's) |
DPP4 INHIBITORS
(gliptins) |
THIAZOLINEDIONES
(glitazones) |
Sulphonylureas
(- ide's) |
BIGUANIDES
(metformin) |
SGLT2 INHIBITORS
(glifflozins) |
GLP1 RECEPTOR AGONISTS
(- tide's) |
DPP4 INHIBITORS
(gliptins) |
THIAZOLINEDIONES
(glitazones) |
Sulphonylureas
(- ide's) |